News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Creative Bioarray -- the First Commercial Entity Specialized in Building Up the Largest Tissue-Sharing Platform


7/19/2013 9:42:42 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

July 19, 2013 -- The shortage of access ability to human specimens for reference has limited the steps of basic bioscience and preclinical researches. Based on this, Creative Bioarray determined to be the first commercial entity specialized in building up the largest tissue-sharing platform by integrating the detailed clinical information of all the tissue samples.

Creative Bioarray, locating in Long Island, New York, is founded as a biomedical company that focuses on providing comprehensive biotechnology and pharmaceutical array services and products for high-throughput analysis. With quality tissue, antibody, protein and cell array technology, Creative Bioarray is able to efficiently analyze the concurrent expression and function of proteins involved in inflammation, angiogenesis, apoptosis, cell growth, and signal transduction from a single biological sample. So far, Creative Bioarray has collaborated with many biotech and pharmaceutical companies, as well as hospitals and academic research laboratories all over the world. Creative Bioarray has a database that contains over 500,000 human tissue samples and 30,000 animal tissue samples. To continuously facilitate studies, Creative Bioarray has perfected and expanded its product and service lists to meet biomedical research requirements. Being one of the largest commercially available banks of paraffin embedded and frozen tissues as well as its extensive and intensive platform, Creative Bioarray is confident to meet kinds of challenges.

Contact Web: http://www.creative-bioarray.com/ Tel: 1-631-624-4882 Email: info@creative-bioarray.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES